Curis
CRIS
#11014
Rank
S$4.59 M
Marketcap
S$1.90
Share price
-0.67%
Change (1 day)
-9.91%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): S-$30.45

According to Curis's latest financial reports the company's current EPS (TTM) is S-$30.29. In 2025 the company made an earnings per share (EPS) of S-$30.29 an increase over its 2024 EPS that were of S-$178.96.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$30.450.52%
2025S-$30.29-83.07%
2024S-$178.96-22.15%
2023S-$229.88-26.17%
2022S-$311.3422.3%
2021S-$254.57-25.37%
2020S-$341.12-30.93%
2019S-$493.87-2.02%
2018S-$504.05
2016S-$1,146-10%
2015S-$1,273138.1%
2014S-$534.6040%
2013S-$381.86-25%
2012S-$509.1466.67%
2011S-$305.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.67-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$4.53-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.46-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$3.98-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S-$5.42-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
S-$6.42-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S-$0.22-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA